SCHEMBL332799

SCHEMBL332799

CC(F)C([O])(F)F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14814227 0.78
SCHEMBL4954229 0.75
SCHEMBL2685890 0.75
SCHEMBL17729853 0.74
SCHEMBL1052204 0.74
SCHEMBL1557 0.73
SCHEMBL1172952 0.73
SCHEMBL24871 0.73
SCHEMBL17729848 0.72
SCHEMBL21487485 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 654 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4339188-A1 QUINAZOLINE COMPOUND, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF Shanghai Pharmaceuticals Holding Co., Ltd. (CN) 2024-03-20 EP claimed
CN-117327000-A Biphenyl tetrahydropyrrole compound and preparation method and application thereof 海南因瑞生物医药科技有限公司 2024-01-02 CN claimed
CN-115232129-B PARP1 selective inhibitor and preparation method and application thereof 上海闻耐医药科技有限公司 2023-12-01 CN claimed
CN-114591312-B Sulfone and sulfoxide compounds, preparation method and medical application thereof 中国药科大学 2023-07-28 CN claimed
US-20230192620-A1 ANILINE COMPOUND USED AS RORy REGULATOR SHANGHAI LITEDD CO., LTD. (CN) 2023-06-22 US claimed
EP-4151626-A1 ANILINE COMPOUND USED AS RORy REGULATOR Shanghai Litedd Co., Ltd. (CN) 2023-03-22 EP claimed
WO-2022237903-A1 QUINAZOLINE COMPOUND, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF 上海医药集团股份有限公司 2022-11-17 WO claimed
CN-115340537-A Quinazoline compound, preparation method and application thereof 上海医药集团股份有限公司 2022-11-15 CN claimed
CN-115232129-A PARP1 selective inhibitor and preparation method and application thereof 上海闻耐医药科技有限公司 2022-10-25 CN claimed
CN-111635373-B Polycyclic sulfonamide ROR gamma modulators 山东轩竹医药科技有限公司 2022-07-12 CN claimed
US-8097621-B2 Pyrazolo[4,3-d]pyrimidines as phosphodiesterase inhibitors PFIZER INC. (US) 2012-01-17 US claimed
US-20100137322-A1 NOVEL N-(8-HETEROARYLTETRAHYDRONAPHTALENE-2YL) OR N-(5-HETEROARYLCHROMANE-3-YL) CARBOXAMIDE DERIVATIVES FOR THE TREATMENT OF PAIN ASTRAZENECA AB (SE) 2010-06-03 US claimed
EP-2158198-A2 NOVEL N- (8HETEROARYLTETRAHYDRONAPHTALENE-2YL) OR N- (5- HETEROARYLCHROMANE-3-YL) CARBOXAMIDE DERIVATIVES FOR THE TREATMENT OF PAIN AstraZeneca AB (SE) 2010-03-03 EP claimed
US-20090247539-A1 Novel Pharmaceuticals PFIZER INC 2009-10-01 US claimed
US-20090042957-A1 Substituted Oxyarenes BAYER CROPSCIENCE AG (DE) 2009-02-12 US claimed
WO-2008130320-A2 NOVEL N- (8-HETEROARYLTETRAHYDRONAPHTALENE-2YL) OR N- (5- HETEROARYLCHROMANE-3-YL) CARBOXAMIDE DERIVATIVES FOR THE TREATMENT OF PAIN ASTRAZENECA AB (SE) 2008-10-30 WO claimed
WO-2008130319-A2 NOVEL N-TETRAHYDRONAPHTALENE OR N-CHROMANE CARBOXAMIDE DERIVATIVES FOR THE TREATMENT OF PAIN ASTRAZENECA AB (SE) 2008-10-30 WO claimed
EP-1831145-A1 SUBSTITUTED OXYARENES Bayer CropScience Aktiengesellschaft (DE) 2007-09-12 EP claimed
WO-2006069685-A1 SUBSTITUTED OXYARENES BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2006-07-06 WO claimed
US-20050245544-A1 Novel pharmaceuticals AMPLIFIED PROTEOMICS INC. 2005-11-03 US claimed